Loss of heterozygosity at 10q in tumors of the upper respiratory tract is associated with poor prognosis

Daniela Gasparotto, Tamara Vukosavljevic, Sara Piccinin, Luigi Barzan, Sandro Sulfaro, Michela Armellin, Mauro Boiocchi, Roberta Maestro

Research output: Contribution to journalArticle

Abstract

Frequent loss of a specific chromosomic region in cancers is often associated with inactivation of a tumor-suppressor gene. The long arm of chromosome 10 is deleted in several types of tumor, among them squamous-cell carcinomas of the head and neck (HNSCC). To determine the role of 10q deletions in the tumorigenesis of the upper respiratory tract, 47 HNSCCs were examined for loss of heterozygosity (LOH) at 10q: 43% of the cases analyzed showed LOH at 10q, and 2 distinct hot spots of deletion were identified, at 10q22-23 and 10q25-26. The possible involvement of pTEN/MMAC1, a tumor- suppressor gene mapped at 10q23, was also evaluated. No mutation, homozygous deletion or loss of expression of pTEN/MMAC1 was detected, indicating that inactivation of this gene plays a minor role in HNSCC development. Interestingly, the frequency of deletion at 10q was greater in invasive carcinoma than in adjacent carcinoma in situ, and a significant association between LOH and poor prognosis was observed. Taken together, our results suggest the presence in the long arm of chromosome 10 of (a) tumor- suppressor gene(s) other than pTEN/MMAC1 and presumably involved in the malignant progression of tumors of the upper respiratory tract.

Original languageEnglish
Pages (from-to)432-436
Number of pages5
JournalInternational Journal of Cancer
Volume84
Issue number4
DOIs
Publication statusPublished - 1999

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Loss of heterozygosity at 10q in tumors of the upper respiratory tract is associated with poor prognosis'. Together they form a unique fingerprint.

Cite this